Ildong files patent for PDF inhibitors

Published: 2009-01-15 06:56:00

Updated: 2009-01-15 06:56:00

lldong Pharm said it has recently filed a patent for novel peptide deformylase inhibitors and manufacturing methods thereof in U.S., Japan, Europe as well as Korea

Peptide deformylase (PDF), a metallohydrolase essential for bacterial growth, is an attractive target for use in the discovery of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK